However, if 60% of breast cancers overexpress GLUT-1, we can hypothesize that cancer cells that do not overexpress GLUT-1 use another metabolic pathway or overexpress other glucose transporters than GLUT-1. The gene discussed is SLC2A1; the disease is breast carcinoma.